Miembros Charles G. Drake, MD, PhD NewYork-Presbyterian / Columbia University Medical Center and Johnson & Johnson Innovative Medicine New York, NY Dr. Charles G. Drake is the co-leader of the Tumor Biology and Microenvironment Program and the co-director of the Cancer Immunotherapy Program at NewYork-Presbyterian / Columbia University Medical Center. Additionally, Dr. Drake is the vice president, Immuno-oncology, at Johnson & Johnson Innovative Medicine. Dr. Drake’s areas of expertise include immunotherapy and the diagnosis and treatment of cancers of the prostate, kidney, bladder, and testes. He’s shown how targeting the immune checkpoint LAG-3 can improve the effectiveness of anti-cancer immune responses, and that it works well in combination with anti-PD-1 immunotherapy. He also continues to explore how we can improve the ability of anti-cancer T cells to eliminate tumors. In addition to being a member of CRI’s Scientific Advisory Council, Dr. Drake serves on the CLIP Grant Review Committee.
